MPAC

MPAC GROUP PLC ORD 25P

Stock London Stock Exchange – Stock Market Prices, News & Analysis

MPAC Group PLC manufactures packaging solutions, including secure and custom packaging for the pharmaceutical and healthcare industries.

£ 2.23
2.20 %

MPAC GROUP PLC ORD 25P

£ 2.23
2.20 %
MPAC

MPAC Group PLC manufactures packaging solutions, including secure and custom packaging for the pharmaceutical and healthcare industries.

Price history of MPAC GROUP PLC ORD 25P
Price history of MPAC GROUP PLC ORD 25P

Performance & Momentum

6 Months 28.80 %
1 Year 45.06 %
3 Years 5.32 %
5 Years 59.91 %

Strategic Analysis

MPAC GROUP PLC ORD 25P • 2026

MPAC Group positions itself as a specialized provider of secure, custom packaging solutions, mainly for the pharmaceutical and healthcare sectors. Its business model relies on technical innovation and customization, creating a barrier to entry in a high-value niche market.

Strengths
  • Recognized expertise in specialized packaging for regulated and demanding industries
  • Ability to develop tailor-made solutions that meet specific requirements
  • Positioning in highly regulated segments that provides a degree of demand resilience
Weaknesses
  • Fragile financial performance in recent years, undermining investor confidence
  • Significant exposure to the UK market, which may be constrained by economic pressures
Momentum

Despite recent positive momentum reflecting a renewed interest, the multi-year trend remains negative, indicating structural challenges to overcome. This dynamic suggests a period of adjustment in which the valuation could be attractive for an investor looking for a turnaround, but with a high-risk profile.

Similar stocks to MPAC GROUP PLC ORD 25P

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone